home / lobbying / lobbying_filings_raw

lobbying_filings_raw: ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json
ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac Q2 30792 PARRY, ROMANI, DECONCINI & SYMMS 136195 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 second_quarter 2011-07-08T16:03:55.353000-04:00 11250.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac/", "filing_uuid": "ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2011, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac/print/", "filing_document_content_type": "text/html", "income": "11250.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Romano Romani, President", "dt_posted": "2011-07-08T16:03:55.353000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "517 C Street, NE", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 30792, "url": "https://lda.senate.gov/api/v1/registrants/30792/", "house_registrant_id": 30115, "name": "PARRY, ROMANI, DECONCINI & SYMMS", "description": "Consulting", "address_1": "517 C Street NE", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ROMANO ROMANI", "contact_telephone": "+1 202-547-4000", "dt_updated": "2026-02-20T12:11:07.230525-05:00"}, "client": {"id": 136195, "url": "https://lda.senate.gov/api/v1/clients/136195/", "client_id": 1004517, "name": "WEDGEWOOD VILLAGE PHARMACY, INC.", "general_description": "Retail Pharmacy.", "client_government_entity": false, "client_self_select": false, "state": "NJ", "state_display": "New Jersey", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2008-10-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet.\nLegislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31170, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": null, "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 13252, "prefix": null, "prefix_display": null, "first_name": "ROMANO", "nickname": null, "middle_name": null, "last_name": "ROMANI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5895, "prefix": null, "prefix_display": null, "first_name": "STEVE", "nickname": null, "middle_name": null, "last_name": "SYMMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 43346, "prefix": "mr", "prefix_display": "MR.", "first_name": "EDWARD", "nickname": null, "middle_name": "H", "last_name": "BAXTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet.\n\nProposals to amend the Controlled Substances Act to clarify the definition of \"dispense\" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31170, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": null, "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 23447, "prefix": "mr", "prefix_display": "MR.", "first_name": "THADDEUS", "nickname": null, "middle_name": "E", "last_name": "STROM", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 43346, "prefix": "mr", "prefix_display": "MR.", "first_name": "EDWARD", "nickname": null, "middle_name": "H", "last_name": "BAXTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet.\nLegislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31170, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": null, "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 13252, "prefix": null, "prefix_display": null, "first_name": "ROMANO", "nickname": null, "middle_name": null, "last_name": "ROMANI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5895, "prefix": null, "prefix_display": null, "first_name": "STEVE", "nickname": null, "middle_name": null, "last_name": "SYMMS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 43346, "prefix": "mr", "prefix_display": "MR.", "first_name": "EDWARD", "nickname": null, "middle_name": "H", "last_name": "BAXTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []}

Links from other tables

  • 3 rows from filing_uuid in lobbying_activities
  • 5 rows from filing_uuid in lobbying_lobbyists
Powered by Datasette · Queries took 2.234ms